Area of research
Cardiology and Cardiovascular Medicine · Internal Medicine
Research interest
Research interests include Atrial Fibrillation Management and Outcomes, Cardiac pacing and defibrillation studies, Cardiac Arrhythmias and Treatments, and Cardiac electrophysiology and arrhythmias.
Atrial fibrillation burden in clinical practice, research, and technology development: a clinical consensus statement of the European Society of Cardiology Council on Stroke and the European Heart Rhythm Association
Apixaban versus aspirin for stroke prevention in people with subclinical atrial fibrillation and a history of stroke or transient ischaemic attack: subgroup analysis of the ARTESiA randomised controlled trial
Artificial intelligence for direct-to-physician reporting of ambulatory electrocardiography
Antithrombotic Therapy after Successful Catheter Ablation for Atrial Fibrillation
Hypertension and Atrial Fibrillation: A Frontier Review From the AF-SCREEN International Collaboration
Recent-onset atrial fibrillation: challenges and opportunities
Transforming atrial fibrillation management by targeting comorbidities and reducing atrial fibrillation burden: the 10th AFNET/EHRA consensus conference
Device-Detected Atrial Fibrillation in Patients With and Without Cryptogenic Ischemia: The ANTARCTICA Pooled Analysis
Clinical significance of a new diagnosis of atrial fibrillation in patients with vascular disease
Alcohol Intake and Cardiovascular Outcomes in Patients With Atrial Fibrillation: <scp>RE</scp>‐<scp>LY AF</scp> Registry Analysis
Apixaban for stroke prevention in subclinical atrial fibrillation detected by an implantable cardiac monitor: A subgroup analysis of ARTESiA
Apixaban to Prevent Recurrence After Cryptogenic Stroke in Patients With Atrial Cardiopathy
Left Atrial Appendage Closure after Ablation for Atrial Fibrillation
Longer and better lives for patients with atrial fibrillation: the 9th AFNET/EHRA consensus conference
Embolic strokes of undetermined source: a clinical consensus statement of the ESC Council on Stroke, the European Association of Cardiovascular Imaging and the European Heart Rhythm Association of the ESC
Apixaban vs Aspirin According to CHA2DS2-VASc Score in Subclinical Atrial Fibrillation
Anticoagulation in device-detected atrial fibrillation with or without vascular disease: a combined analysis of the NOAH-AFNET 6 and ARTESiA trials
Residual Stroke Risk Among Patients With Atrial Fibrillation Prescribed Oral Anticoagulants: A Patient‐Level Meta‐Analysis From COMBINE AF
Implantable cardioverter defibrillator use in arrhythmogenic right ventricular cardiomyopathy in North America and Europe
A Clinical Diagnostic Test for Calcium Release Deficiency Syndrome
Atrial cardiopathy biomarkers and atrial fibrillation in the ARCADIA trial
Direct oral anticoagulants for stroke prevention in patients with device-detected atrial fibrillation: assessing net clinical benefit
Sodium Intake and Incident Atrial Fibrillation in Individuals With Vascular Disease
Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation
Effects of oral anticoagulation in people with atrial fibrillation after spontaneous intracranial haemorrhage (COCROACH): prospective, individual participant data meta-analysis of randomised trials
Colchicine to Prevent Atrial Fibrillation Recurrence After Catheter Ablation: A Randomized, Placebo-Controlled Trial
STICH3C: Rationale and Study Protocol
Self-administered intranasal etripamil using a symptom-prompted, repeat-dose regimen for atrioventricular-nodal-dependent supraventricular tachycardia (RAPID): a multicentre, randomised trial
Early diagnosis and better rhythm management to improve outcomes in patients with atrial fibrillation: the 8th AFNET/EHRA consensus conference
Consumer-Led Screening for Atrial Fibrillation: Frontier Review of the AF-SCREEN International Collaboration